Article

barrons.com on 2022-09-29 17:54

This Is What Wall Street Has Wrong About Novartis, Says CEO4 min read

Vas Narasimhan, CEO of Novartis, talks about the Big Pharma company's new focus on the U.S. market—and why he believes investors are undervaluing its ...

Related news